LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 31 of 497
Next
>>
>
751 to 775 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	A443654	0.37	uM	LJP6	1	I22	72	hr	1097	690	3769	0.1831	-0.1524
BT-20	A443654	0.37	uM	LJP6	2	I22	72	hr	1097	740	3769	0.1963	-0.1337
BT-20	A443654	0.37	uM	LJP6	3	I22	72	hr	1097	756	3769	0.2006	-0.1277
BT-20	OSI-027	0.37	uM	LJP6	1	E10	72	hr	1097	2442	3769	0.6478	0.5032
BT-20	OSI-027	0.37	uM	LJP6	2	E10	72	hr	1097	2442	3769	0.6478	0.5032
BT-20	OSI-027	0.37	uM	LJP6	3	E10	72	hr	1097	2256	3769	0.5985	0.4336
BT-20	XMD11-85h	0.37	uM	LJP6	1	P22	72	hr	1097	2895	3769	0.7680	0.6727
BT-20	XMD11-85h	0.37	uM	LJP6	2	P22	72	hr	1097	3091	3769	0.8200	0.7461
BT-20	XMD11-85h	0.37	uM	LJP6	3	P22	72	hr	1097	2973	3769	0.7887	0.7019
BT-20	HG-6-64-01	0.37	uM	LJP6	1	M04	72	hr	1097	2610	3769	0.6924	0.5661
BT-20	HG-6-64-01	0.37	uM	LJP6	2	M04	72	hr	1097	2567	3769	0.6810	0.5500
BT-20	HG-6-64-01	0.37	uM	LJP6	3	M04	72	hr	1097	2606	3769	0.6913	0.5646
BT-20	WH-4-025	0.37	uM	LJP5	1	O10	72	hr	1097	2578	3769	0.6839	0.5541
BT-20	WH-4-025	0.37	uM	LJP5	2	O10	72	hr	1097	3183	3769	0.8444	0.7805
BT-20	WH-4-025	0.37	uM	LJP5	3	O10	72	hr	1097	2683	3769	0.7118	0.5934
BT-20	WZ-4-145	0.37	uM	LJP6	1	J22	72	hr	1097	2828	3769	0.7502	0.6477
BT-20	WZ-4-145	0.37	uM	LJP6	2	J22	72	hr	1097	2666	3769	0.7073	0.5870
BT-20	WZ-4-145	0.37	uM	LJP6	3	J22	72	hr	1097	2523	3769	0.6693	0.5335
BT-20	XMD16-144	0.37	uM	LJP5	1	M10	72	hr	1097	1331	3769	0.3531	0.0875
BT-20	XMD16-144	0.37	uM	LJP5	2	M10	72	hr	1097	1334	3769	0.3539	0.0886
BT-20	XMD16-144	0.37	uM	LJP5	3	M10	72	hr	1097	1306	3769	0.3465	0.0781
BT-20	Brivanib	0.37	uM	LJP5	1	P16	72	hr	1097	3608	3769	0.9572	0.9396
BT-20	Brivanib	0.37	uM	LJP5	2	P16	72	hr	1097	3979	3769	1.0556	1.0784
BT-20	Brivanib	0.37	uM	LJP5	3	P16	72	hr	1097	3510	3769	0.9312	0.9029
BT-20	Buparlisib	0.37	uM	LJP5	1	H04	72	hr	1097	1879	3769	0.4985	0.2925

|<
<<
Previous
Page 31 of 497
Next
>>
>
751 to 775 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)